News | July 23, 2009

Dual-Energy CT Compares Well With SPECT, Angiography in Study

Assessment of stenosis in a coronary artery using dual-source CT.


July 23, 2009 – Dual-energy CT used as a single examination might be promising for the integrative analysis of the coronary artery morphology and the myocardial blood supply and is in good agreement with angiography and SPECT, according to a study published in this month’s issue of The American Journal of Cardiology (volume 104, issue 3, pages 318-326, August 2009).

To evaluate the performance of dual-energy computed tomography (DECT) for integrative imaging of the coronary artery morphology and the myocardial blood supply, 36 patients (15 women, mean age 57 ± 11 years) with equivocal or incongruous single photon emission CT (SPECT) results were investigated by a single-contrast medium-enhanced, retrospectively electrocardiographic-gated, DECT scan with simultaneous acquisition of high and low X-ray spectra. Thirteen patients subsequently underwent invasive coronary angiography. The DECT data were used to reconstruct anatomic coronary CT angiographic images and to map the myocardial iodine distribution within the left ventricular myocardium.

Two independent observers analyzed all DECT studies for stenosis and myocardial iodine defects. A segmental comparison was performed between the stress/rest SPECT perfusion defects and DECT iodine defects and between the angiography and coronary CT angiographic findings for stenosis. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were estimated.

Overall, researchers said DECT had 92 percent sensitivity and 93 percent specificity, with 93 percent accuracy for detecting any type of myocardial perfusion defect seen on SPECT. Contrast defects at DECT correctly identified 85 (96 percent) of 89 fixed and 60 (88 percent) of 68 reversible myocardial perfusion defects. Compared with angiography, coronary CT angiography had 90 percent sensitivity, 94 percent specificity, and 93 percent accuracy for the detection of more than 50 percent stenosis.

The study was conducted by the Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston; the Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston; the Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore; and the Department of Radiology, University of Navarra, Pamplona, Spain.

For more information: www.ajconline.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now